Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Artemisinin Antimalarial Drugs Market Growth 2022-2028

  • LP 4917052
  • 96 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Artemisinin Antimalarial Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Artemisinin Antimalarial Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Artemisinin Antimalarial Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Artemisinin Antimalarial Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Artemisinin Antimalarial Drugs market, reaching US$ million by the year 2028. As for the Europe Artemisinin Antimalarial Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Artemisinin Antimalarial Drugs players cover Novartis, Sanofi, Ajanta, and Cipla, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin Antimalarial Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Artesunate

Dihydroartemisinin

Artemether

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Prevention

Treatment

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novartis

Sanofi

Ajanta

Cipla

Ipca

Guilin Medicine

GlaxoSmithKline

Mylan Labs

Roche

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Artemisinin Antimalarial Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Artemisinin Antimalarial Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Artemisinin Antimalarial Drugs by Country/Region, 2017, 2022 & 2028

2.2 Artemisinin Antimalarial Drugs Segment by Type

2.2.1 Artesunate

2.2.2 Dihydroartemisinin

2.2.3 Artemether

2.3 Artemisinin Antimalarial Drugs Sales by Type

2.3.1 Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Artemisinin Antimalarial Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Artemisinin Antimalarial Drugs Sale Price by Type (2017-2022)

2.4 Artemisinin Antimalarial Drugs Segment by Application

2.4.1 Prevention

2.4.2 Treatment

2.4.3 Other

2.5 Artemisinin Antimalarial Drugs Sales by Application

2.5.1 Global Artemisinin Antimalarial Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Artemisinin Antimalarial Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Artemisinin Antimalarial Drugs Sale Price by Application (2017-2022)

3 Global Artemisinin Antimalarial Drugs by Company

3.1 Global Artemisinin Antimalarial Drugs Breakdown Data by Company

3.1.1 Global Artemisinin Antimalarial Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Artemisinin Antimalarial Drugs Sales Market Share by Company (2020-2022)

3.2 Global Artemisinin Antimalarial Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Artemisinin Antimalarial Drugs Revenue by Company (2020-2022)

3.2.2 Global Artemisinin Antimalarial Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Artemisinin Antimalarial Drugs Sale Price by Company

3.4 Key Manufacturers Artemisinin Antimalarial Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Artemisinin Antimalarial Drugs Product Location Distribution

3.4.2 Players Artemisinin Antimalarial Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Artemisinin Antimalarial Drugs by Geographic Region

4.1 World Historic Artemisinin Antimalarial Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Artemisinin Antimalarial Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Artemisinin Antimalarial Drugs Annual Revenue by Geographic Region

4.2 World Historic Artemisinin Antimalarial Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Artemisinin Antimalarial Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Artemisinin Antimalarial Drugs Annual Revenue by Country/Region

4.3 Americas Artemisinin Antimalarial Drugs Sales Growth

4.4 APAC Artemisinin Antimalarial Drugs Sales Growth

4.5 Europe Artemisinin Antimalarial Drugs Sales Growth

4.6 Middle East & Africa Artemisinin Antimalarial Drugs Sales Growth

5 Americas

5.1 Americas Artemisinin Antimalarial Drugs Sales by Country

5.1.1 Americas Artemisinin Antimalarial Drugs Sales by Country (2017-2022)

5.1.2 Americas Artemisinin Antimalarial Drugs Revenue by Country (2017-2022)

5.2 Americas Artemisinin Antimalarial Drugs Sales by Type

5.3 Americas Artemisinin Antimalarial Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Artemisinin Antimalarial Drugs Sales by Region

6.1.1 APAC Artemisinin Antimalarial Drugs Sales by Region (2017-2022)

6.1.2 APAC Artemisinin Antimalarial Drugs Revenue by Region (2017-2022)

6.2 APAC Artemisinin Antimalarial Drugs Sales by Type

6.3 APAC Artemisinin Antimalarial Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Artemisinin Antimalarial Drugs by Country

7.1.1 Europe Artemisinin Antimalarial Drugs Sales by Country (2017-2022)

7.1.2 Europe Artemisinin Antimalarial Drugs Revenue by Country (2017-2022)

7.2 Europe Artemisinin Antimalarial Drugs Sales by Type

7.3 Europe Artemisinin Antimalarial Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Artemisinin Antimalarial Drugs by Country

8.1.1 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Type

8.3 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Artemisinin Antimalarial Drugs

10.3 Manufacturing Process Analysis of Artemisinin Antimalarial Drugs

10.4 Industry Chain Structure of Artemisinin Antimalarial Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Artemisinin Antimalarial Drugs Distributors

11.3 Artemisinin Antimalarial Drugs Customer

12 World Forecast Review for Artemisinin Antimalarial Drugs by Geographic Region

12.1 Global Artemisinin Antimalarial Drugs Market Size Forecast by Region

12.1.1 Global Artemisinin Antimalarial Drugs Forecast by Region (2023-2028)

12.1.2 Global Artemisinin Antimalarial Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Artemisinin Antimalarial Drugs Forecast by Type

12.7 Global Artemisinin Antimalarial Drugs Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Artemisinin Antimalarial Drugs Product Offered

13.1.3 Novartis Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 Sanofi

13.2.1 Sanofi Company Information

13.2.2 Sanofi Artemisinin Antimalarial Drugs Product Offered

13.2.3 Sanofi Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Main Business Overview

13.2.5 Sanofi Latest Developments

13.3 Ajanta

13.3.1 Ajanta Company Information

13.3.2 Ajanta Artemisinin Antimalarial Drugs Product Offered

13.3.3 Ajanta Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Ajanta Main Business Overview

13.3.5 Ajanta Latest Developments

13.4 Cipla

13.4.1 Cipla Company Information

13.4.2 Cipla Artemisinin Antimalarial Drugs Product Offered

13.4.3 Cipla Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Cipla Main Business Overview

13.4.5 Cipla Latest Developments

13.5 Ipca

13.5.1 Ipca Company Information

13.5.2 Ipca Artemisinin Antimalarial Drugs Product Offered

13.5.3 Ipca Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Ipca Main Business Overview

13.5.5 Ipca Latest Developments

13.6 Guilin Medicine

13.6.1 Guilin Medicine Company Information

13.6.2 Guilin Medicine Artemisinin Antimalarial Drugs Product Offered

13.6.3 Guilin Medicine Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Guilin Medicine Main Business Overview

13.6.5 Guilin Medicine Latest Developments

13.7 GlaxoSmithKline

13.7.1 GlaxoSmithKline Company Information

13.7.2 GlaxoSmithKline Artemisinin Antimalarial Drugs Product Offered

13.7.3 GlaxoSmithKline Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 GlaxoSmithKline Main Business Overview

13.7.5 GlaxoSmithKline Latest Developments

13.8 Mylan Labs

13.8.1 Mylan Labs Company Information

13.8.2 Mylan Labs Artemisinin Antimalarial Drugs Product Offered

13.8.3 Mylan Labs Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Mylan Labs Main Business Overview

13.8.5 Mylan Labs Latest Developments

13.9 Roche

13.9.1 Roche Company Information

13.9.2 Roche Artemisinin Antimalarial Drugs Product Offered

13.9.3 Roche Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Roche Main Business Overview

13.9.5 Roche Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Artemisinin Antimalarial Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Artemisinin Antimalarial Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Artesunate

Table 4. Major Players of Dihydroartemisinin

Table 5. Major Players of Artemether

Table 6. Global Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)

Table 7. Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2022)

Table 8. Global Artemisinin Antimalarial Drugs Revenue by Type (2017-2022) & ($ million)

Table 9. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2017-2022)

Table 10. Global Artemisinin Antimalarial Drugs Sale Price by Type (2017-2022) & (US$/G)

Table 11. Global Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)

Table 12. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2022)

Table 13. Global Artemisinin Antimalarial Drugs Revenue by Application (2017-2022)

Table 14. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2017-2022)

Table 15. Global Artemisinin Antimalarial Drugs Sale Price by Application (2017-2022) & (US$/G)

Table 16. Global Artemisinin Antimalarial Drugs Sales by Company (2020-2022) & (KG)

Table 17. Global Artemisinin Antimalarial Drugs Sales Market Share by Company (2020-2022)

Table 18. Global Artemisinin Antimalarial Drugs Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Artemisinin Antimalarial Drugs Revenue Market Share by Company (2020-2022)

Table 20. Global Artemisinin Antimalarial Drugs Sale Price by Company (2020-2022) & (US$/G)

Table 21. Key Manufacturers Artemisinin Antimalarial Drugs Producing Area Distribution and Sales Area

Table 22. Players Artemisinin Antimalarial Drugs Products Offered

Table 23. Artemisinin Antimalarial Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Artemisinin Antimalarial Drugs Sales by Geographic Region (2017-2022) & (KG)

Table 27. Global Artemisinin Antimalarial Drugs Sales Market Share Geographic Region (2017-2022)

Table 28. Global Artemisinin Antimalarial Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Artemisinin Antimalarial Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Artemisinin Antimalarial Drugs Sales by Country/Region (2017-2022) & (KG)

Table 31. Global Artemisinin Antimalarial Drugs Sales Market Share by Country/Region (2017-2022)

Table 32. Global Artemisinin Antimalarial Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Artemisinin Antimalarial Drugs Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Artemisinin Antimalarial Drugs Sales by Country (2017-2022) & (KG)

Table 35. Americas Artemisinin Antimalarial Drugs Sales Market Share by Country (2017-2022)

Table 36. Americas Artemisinin Antimalarial Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Artemisinin Antimalarial Drugs Revenue Market Share by Country (2017-2022)

Table 38. Americas Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)

Table 39. Americas Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2022)

Table 40. Americas Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)

Table 41. Americas Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2022)

Table 42. APAC Artemisinin Antimalarial Drugs Sales by Region (2017-2022) & (KG)

Table 43. APAC Artemisinin Antimalarial Drugs Sales Market Share by Region (2017-2022)

Table 44. APAC Artemisinin Antimalarial Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Artemisinin Antimalarial Drugs Revenue Market Share by Region (2017-2022)

Table 46. APAC Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)

Table 47. APAC Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2022)

Table 48. APAC Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)

Table 49. APAC Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2022)

Table 50. Europe Artemisinin Antimalarial Drugs Sales by Country (2017-2022) & (KG)

Table 51. Europe Artemisinin Antimalarial Drugs Sales Market Share by Country (2017-2022)

Table 52. Europe Artemisinin Antimalarial Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Artemisinin Antimalarial Drugs Revenue Market Share by Country (2017-2022)

Table 54. Europe Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)

Table 55. Europe Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2022)

Table 56. Europe Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)

Table 57. Europe Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Country (2017-2022) & (KG)

Table 59. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)

Table 63. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)

Table 65. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Artemisinin Antimalarial Drugs

Table 67. Key Market Challenges & Risks of Artemisinin Antimalarial Drugs

Table 68. Key Industry Trends of Artemisinin Antimalarial Drugs

Table 69. Artemisinin Antimalarial Drugs Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Artemisinin Antimalarial Drugs Distributors List

Table 72. Artemisinin Antimalarial Drugs Customer List

Table 73. Global Artemisinin Antimalarial Drugs Sales Forecast by Region (2023-2028) & (KG)

Table 74. Global Artemisinin Antimalarial Drugs Sales Market Forecast by Region

Table 75. Global Artemisinin Antimalarial Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Artemisinin Antimalarial Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Artemisinin Antimalarial Drugs Sales Forecast by Country (2023-2028) & (KG)

Table 78. Americas Artemisinin Antimalarial Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Artemisinin Antimalarial Drugs Sales Forecast by Region (2023-2028) & (KG)

Table 80. APAC Artemisinin Antimalarial Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Artemisinin Antimalarial Drugs Sales Forecast by Country (2023-2028) & (KG)

Table 82. Europe Artemisinin Antimalarial Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Artemisinin Antimalarial Drugs Sales Forecast by Country (2023-2028) & (KG)

Table 84. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Artemisinin Antimalarial Drugs Sales Forecast by Type (2023-2028) & (KG)

Table 86. Global Artemisinin Antimalarial Drugs Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Artemisinin Antimalarial Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Artemisinin Antimalarial Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Artemisinin Antimalarial Drugs Sales Forecast by Application (2023-2028) & (KG)

Table 90. Global Artemisinin Antimalarial Drugs Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Artemisinin Antimalarial Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Artemisinin Antimalarial Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 93. Novartis Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors

Table 94. Novartis Artemisinin Antimalarial Drugs Product Offered

Table 95. Novartis Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 96. Novartis Main Business

Table 97. Novartis Latest Developments

Table 98. Sanofi Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors

Table 99. Sanofi Artemisinin Antimalarial Drugs Product Offered

Table 100. Sanofi Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 101. Sanofi Main Business

Table 102. Sanofi Latest Developments

Table 103. Ajanta Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors

Table 104. Ajanta Artemisinin Antimalarial Drugs Product Offered

Table 105. Ajanta Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 106. Ajanta Main Business

Table 107. Ajanta Latest Developments

Table 108. Cipla Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors

Table 109. Cipla Artemisinin Antimalarial Drugs Product Offered

Table 110. Cipla Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 111. Cipla Main Business

Table 112. Cipla Latest Developments

Table 113. Ipca Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors

Table 114. Ipca Artemisinin Antimalarial Drugs Product Offered

Table 115. Ipca Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 116. Ipca Main Business

Table 117. Ipca Latest Developments

Table 118. Guilin Medicine Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors

Table 119. Guilin Medicine Artemisinin Antimalarial Drugs Product Offered

Table 120. Guilin Medicine Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 121. Guilin Medicine Main Business

Table 122. Guilin Medicine Latest Developments

Table 123. GlaxoSmithKline Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors

Table 124. GlaxoSmithKline Artemisinin Antimalarial Drugs Product Offered

Table 125. GlaxoSmithKline Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 126. GlaxoSmithKline Main Business

Table 127. GlaxoSmithKline Latest Developments

Table 128. Mylan Labs Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors

Table 129. Mylan Labs Artemisinin Antimalarial Drugs Product Offered

Table 130. Mylan Labs Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 131. Mylan Labs Main Business

Table 132. Mylan Labs Latest Developments

Table 133. Roche Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors

Table 134. Roche Artemisinin Antimalarial Drugs Product Offered

Table 135. Roche Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 136. Roche Main Business

Table 137. Roche Latest Developments

List of Figures

Figure 1. Picture of Artemisinin Antimalarial Drugs

Figure 2. Artemisinin Antimalarial Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Artemisinin Antimalarial Drugs Sales Growth Rate 2017-2028 (KG)

Figure 7. Global Artemisinin Antimalarial Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Artemisinin Antimalarial Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Artesunate

Figure 10. Product Picture of Dihydroartemisinin

Figure 11. Product Picture of Artemether

Figure 12. Global Artemisinin Antimalarial Drugs Sales Market Share by Type in 2021

Figure 13. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2017-2022)

Figure 14. Artemisinin Antimalarial Drugs Consumed in Prevention

Figure 15. Global Artemisinin Antimalarial Drugs Market: Prevention (2017-2022) & (KG)

Figure 16. Artemisinin Antimalarial Drugs Consumed in Treatment

Figure 17. Global Artemisinin Antimalarial Drugs Market: Treatment (2017-2022) & (KG)

Figure 18. Artemisinin Antimalarial Drugs Consumed in Other

Figure 19. Global Artemisinin Antimalarial Drugs Market: Other (2017-2022) & (KG)

Figure 20. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2022)

Figure 21. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application in 2021

Figure 22. Artemisinin Antimalarial Drugs Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Artemisinin Antimalarial Drugs Revenue Market Share by Company in 2021

Figure 24. Global Artemisinin Antimalarial Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Artemisinin Antimalarial Drugs Revenue Market Share by Geographic Region in 2021

Figure 26. Global Artemisinin Antimalarial Drugs Sales Market Share by Region (2017-2022)

Figure 27. Global Artemisinin Antimalarial Drugs Revenue Market Share by Country/Region in 2021

Figure 28. Americas Artemisinin Antimalarial Drugs Sales 2017-2022 (KG)

Figure 29. Americas Artemisinin Antimalarial Drugs Revenue 2017-2022 ($ Millions)

Figure 30. APAC Artemisinin Antimalarial Drugs Sales 2017-2022 (KG)

Figure 31. APAC Artemisinin Antimalarial Drugs Revenue 2017-2022 ($ Millions)

Figure 32. Europe Artemisinin Antimalarial Drugs Sales 2017-2022 (KG)

Figure 33. Europe Artemisinin Antimalarial Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Artemisinin Antimalarial Drugs Sales 2017-2022 (KG)

Figure 35. Middle East & Africa Artemisinin Antimalarial Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Americas Artemisinin Antimalarial Drugs Sales Market Share by Country in 2021

Figure 37. Americas Artemisinin Antimalarial Drugs Revenue Market Share by Country in 2021

Figure 38. United States Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Artemisinin Antimalarial Drugs Sales Market Share by Region in 2021

Figure 43. APAC Artemisinin Antimalarial Drugs Revenue Market Share by Regions in 2021

Figure 44. China Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Artemisinin Antimalarial Drugs Sales Market Share by Country in 2021

Figure 51. Europe Artemisinin Antimalarial Drugs Revenue Market Share by Country in 2021

Figure 52. Germany Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Market Share by Country in 2021

Figure 59. Egypt Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Artemisinin Antimalarial Drugs in 2021

Figure 65. Manufacturing Process Analysis of Artemisinin Antimalarial Drugs

Figure 66. Industry Chain Structure of Artemisinin Antimalarial Drugs

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390